Navigation Links
Martek Announces Second Quarter 2008 Financial Results
Date:6/4/2008

mprovement from last year's second quarter resulted from DHA productivity gains at Martek's manufacturing facilities, as well as reductions in ARA costs. Contract manufacturing gross margins were slightly lower than anticipated, but Martek believes that such margins will improve in the third quarter and contract manufacturing margins for the full fiscal year 2008 will be between 5% and 10%.

Research and development expenses in the second quarter of fiscal 2008 were $6.8 million, or approximately 8% of revenue which is similar to prior year levels. The Company's research and development efforts continue to focus on developing new food and beverage applications for life'sDHA(TM), broadening the scientific evidence supporting the benefits of life'sDHA(TM) throughout life, improving manufacturing processes and developing new products to expand the Company's market offerings. In the future, the Company expects to experience quarter-to-quarter fluctuations in research and development expenses primarily due to the timing of outside services, including third-party clinical trial services. The Company anticipates that its research and development spend for the full fiscal year 2008 will also approximate 8% of revenue.

During the second quarter of fiscal 2008, selling, general and administrative expenses were $14.2 million, within the range of the second quarter estimates previously provided. As a percentage of revenue, the Company's selling, general and administrative expenses were 15.7%, consistent with the first quarter. For the full fiscal year 2008, the Company expects S,G & A as a percentage of revenue to be near 16%, compared to 14.6% in fiscal 2007. The spending increase from fiscal 2007 relates primarily to the Company's continued investment in new personnel required to support growth, expansion of marketing efforts designed to increase sales in both infant formula and non-infant formula markets as well as projected increases in the variable component o
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Martek Announces Fourth Quarter and FY 2007 Financial Results
9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... TENN (PRWEB) December 22, 2014 Fertility ... Donor Egg Bank USA , a network of ... country. Through this partnership, patients have fast access to ... in vitro fertilization, IVF . Fertility Associates of Memphis ... offer this fertility treatment option. , Dr. William ...
(Date:12/19/2014)... Dec. 19, 2014 Naurex Inc., a biopharmaceutical ... for diseases of the central nervous system, today announced ... executive officer, will present at the 33 rd ... take place at 3:00 p.m. PST on Tuesday, January ... San Francisco, Calif. ...
(Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/fhh9rj/technology ... "Technology Innovations in Smart Fabrics (Technical Insights)" ... http://photos.prnewswire.com/prnh/20130307/600769 The Research Service ... detailed assessment on technological advancements and market for ... 1. The Smart Fabrics market is expected ...
(Date:12/19/2014)... Ed Bilsky, Ph.D., vice president for Research ... in the Neurosciences (CEN), and professor of pharmacology at ... a member of the prestigious Dana Alliance for Brain ... to receive this honor. , The Dana Alliance ... Dana Foundation. Its mission is to advance public ...
Breaking Biology Technology:Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Technology Innovations in Smart Fabrics (Technical Insights) 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3
... Decision Resources, one of the world,s leading research ... that, owing to increasing generic availability of antihypertensive agents, ... in 2009 to $23 billion in 2019 in the ... Japan. The Pharmacor 2010 findings from the ...
... Partner for Enterprisewide Real Time Location Solution -- RESTON, Virginia, September 28, 2010 ... ... lpUnit=,PRN,; --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
... -- AMSTERDAM, September 28, 2010 ... ... ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) { ...
Cached Biology Technology:Due to Generic Erosion, the Hypertension Drug Market Will Decline by $3 Billion from 2009 to 2019 2Clarian Health and Ekahau Partner for Enterprisewide Real Time Location Solution 2Clarian Health and Ekahau Partner for Enterprisewide Real Time Location Solution 3Clarian Health and Ekahau Partner for Enterprisewide Real Time Location Solution 4Clarian Health and Ekahau Partner for Enterprisewide Real Time Location Solution 5Clarian Health and Ekahau Partner for Enterprisewide Real Time Location Solution 6Clarian Health and Ekahau Partner for Enterprisewide Real Time Location Solution 7Clarian Health and Ekahau Partner for Enterprisewide Real Time Location Solution 8Clarian Health and Ekahau Partner for Enterprisewide Real Time Location Solution 9Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 2Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 3Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 4Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 5Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 6Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 7Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 8Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 9Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 10
(Date:12/10/2014)... Forest Baptist Medical Center today announced plans for a ... Funding for this $50 million capital project is part ... launched next summer. The medical education ... R.J. Reynolds Tobacco Company complex, adjacent to 525@vine in ... plans to be ready to welcome medical students in ...
(Date:12/5/2014)... , Dec. 4, 2014 Increased emphasis ... investments in new testing and inspection technologies. The ... rise to a range of innovative test solutions. ... of Generation Y, which is generally more inclined ... result, product development strategies of test equipment vendors ...
(Date:12/3/2014)... -- As part of our commitment to offering the ... announce the release of a new reader that will ... data that they need. The Atlas 2000 ... readers. Many such devices have serious shortcomings when it ... models force users to navigate numerous complicated steps in ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
... run like clockwork, attuned to temperature, time of day ... Scientists at Rice University and the University of Houston ... process that has confounded researchers for decades: the mechanism ... Until now, synthetic biologists have not been able to ...
... well as obesity leads to the accumulation of fat in ... steatosis. FLD is one of the most prevalent diseases in ... Importantly, FLD increases the risk of liver failure, diabetes and ... The Genes, Development and Disease research team led by ...
... a protected or endangered species requires frequent monitoring ... the survival of threatened animals. Often, scientists study ... Currently, researchers at the University of Missouri are ... forest elephants in protected and unprotected regions of ...
Cached Biology News:Synthetic genetic clock checks the thermometer 2Synthetic genetic clock checks the thermometer 3A CNIO research team discovers new regulators of the most prevalent liver disease 2MU researcher's study of African forest elephants helps guide research efforts in the US 2MU researcher's study of African forest elephants helps guide research efforts in the US 3
Request Info...
Lipofectin Reagent is the reagent of choice for some cell lines; cells of endothelial derivation transfect well with Lipofectin Reagent....
Chicken polyclonal to ADI1 ( Abpromise for all tested applications). Antigen: Full length native protein (purified), corresponding to amino acids 1-179 of Human ADI1. Entrez GeneID: 55256 ...
Request Info...
Biology Products: